403 related articles for article (PubMed ID: 25400085)
1. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous hydrocortisone infusion in Addison's disease.
Løvås K; Husebye ES
Eur J Endocrinol; 2007 Jul; 157(1):109-12. PubMed ID: 17609409
[TBL] [Abstract][Full Text] [Related]
5. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
[TBL] [Abstract][Full Text] [Related]
6. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
[TBL] [Abstract][Full Text] [Related]
8. Current and emerging therapies for Addison's disease.
Napier C; Pearce SH
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):147-53. PubMed ID: 24755997
[TBL] [Abstract][Full Text] [Related]
9. Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency.
Simunkova K; Løvås K; Methlie P; Jovanovic N; Bifulco E; Bronstad I; Lightman SL; Husebye ES; Oksnes M
Horm Metab Res; 2023 Jul; 55(7):471-478. PubMed ID: 37172949
[TBL] [Abstract][Full Text] [Related]
10. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
[TBL] [Abstract][Full Text] [Related]
11. Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy.
Hangaard J; Andersen M; Grodum E; Koldkjaer O; Hagen C
J Clin Endocrinol Metab; 1996 Jul; 81(7):2502-7. PubMed ID: 8675567
[TBL] [Abstract][Full Text] [Related]
12. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
Giordano R; Guaraldi F; Marinazzo E; Fumarola F; Rampino A; Berardelli R; Karamouzis I; Lucchiari M; Manetta T; Mengozzi G; Arvat E; Ghigo E
Endocrine; 2016 Feb; 51(2):360-8. PubMed ID: 26184416
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
Løvås K; Gjesdal CG; Christensen M; Wolff AB; Almås B; Svartberg J; Fougner KJ; Syversen U; Bollerslev J; Falch JA; Hunt PJ; Chatterjee VK; Husebye ES
Eur J Endocrinol; 2009 Jun; 160(6):993-1002. PubMed ID: 19282465
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) secretion in primary adrenal insufficiency: effects of cortisol withdrawal and patterned replacement on GH pulsatility and circadian rhythmicity.
Barkan AL; DeMott-Friberg R; Samuels MH
Pituitary; 2000 Nov; 3(3):175-9. PubMed ID: 11383482
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
Fichna M; Gryczyńska M; Sowińska A; Sowiński J
Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency.
García-Borreguero D; Wehr TA; Larrosa O; Granizo JJ; Hardwick D; Chrousos GP; Friedman TC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4201-6. PubMed ID: 11095454
[TBL] [Abstract][Full Text] [Related]
18. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
[TBL] [Abstract][Full Text] [Related]
19. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
20. Modified-release hydrocortisone to provide circadian cortisol profiles.
Debono M; Ghobadi C; Rostami-Hodjegan A; Huatan H; Campbell MJ; Newell-Price J; Darzy K; Merke DP; Arlt W; Ross RJ
J Clin Endocrinol Metab; 2009 May; 94(5):1548-54. PubMed ID: 19223520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
